Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $438,258 (100.0% shares, 0.0% debt)

Holdings (10)

— ABIOMED INC 41.4%

Value ($000) $181,540 Shares 1,450,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 21.8%

Value ($000) $95,515 Shares 4,592,047 Est. Cost $31.50 Unrealized —

AXGN AXOGEN INC 11.6%

Value ($000) $50,799 Shares 4,861,111 Est. Cost $4.01 Unrealized +154.6%

— ENTELLUS MEDICAL INC 10.2%

Value ($000) $44,597 Shares 3,231,656 Est. Cost $21.90 Unrealized —

— CORIUM 8.9%

Value ($000) $39,097 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 3.3%

Value ($000) $14,484 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 1.6%

Value ($000) $7,011 Shares 1,170,370 Est. Cost $2.95 Unrealized +104.3%

LGND LIGAND 0.7%

Value ($000) $3,281 Shares 30,996 Est. Cost $74.21 Unrealized -11.3%

ACUR ACURA PHARMACEUTICALS INC 0.3%

Value ($000) $1,177 Shares 1,956,397 Est. Cost $3.40 Unrealized -80.9%

— CATALYST 0.2%

Value ($000) $757 Shares 78,622 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	1,450,000	$181,540	41.4%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$95,515	21.8%	$31.50	—	COM	761330109
AXGN	AXOGEN INC	4,861,111	$50,799	11.6%	$4.01	+154.6%	COM	05463X106
—	ENTELLUS MEDICAL INC	3,231,656	$44,597	10.2%	$21.90	—	COM	29363K105
—	CORIUM	9,353,304	$39,097	8.9%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	1,257,468	$14,484	3.3%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$7,011	1.6%	$2.95	+104.3%	COM	58468P206
LGND	LIGAND	30,996	$3,281	0.7%	$74.21	-11.3%	COM	53220K504
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$1,177	0.3%	$3.40	-80.9%	COM	00509L802
—	CATALYST	78,622	$757	0.2%	$4.80	—	COM	14888D109